Straits Times Index
3,330.81 +0.80 (+0.02%) S&P 500
5,352.96 -1.07 (-0.02%) Dow
38,886.17 +78.84 (+0.20%) Nasdaq
17,173.12 -14.78 (-0.09%) Bitcoin USD
70,775.88 -434.01 (-0.61%) CMC Crypto 200
1,474.85 -49.95 (-3.20%)
EW Jan 2025 115.000 call
- Zacks
BD (BDX) Inks Buyout Deal to Expand Smart Connected Care Suite
BD's (BDX) latest agreement is likely to unlock new future value-creation opportunities and expand its portfolio of smart connected care solutions.
- Business Wire
Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR
NEW YORK, June 05, 2024--Edwards Lifesciences (NYSE: EW) today announced the results from an analysis of data from the PARTNER Trials examining outcomes of transcatheter aortic valve replacement (TAVR) patients with a small annulus. Through five-year follow up of more than 1,300 low and intermediate risk SAPIEN 3 valve patients there were excellent clinical outcomes and valve durability irrespective of the patient’s annulus size or sex. These data were presented during the late-breaking clinical
- Simply Wall St.
Edwards Lifesciences (NYSE:EW) Knows How To Allocate Capital
What are the early trends we should look for to identify a stock that could multiply in value over the long term...
